Lack of interleukin-1 type 1 receptor enhances the accumulation of mutant huntingtin in the striatum and exacerbates the neurological phenotypes of Huntington's disease mice

Molecular Brain

Volumn 3, Issue 1, 2010, Pages

  Wang, Chuan En ^a   Li, Shihua ^a   Li, Xiao Jiang ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; HUNTINGTIN; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR; GLIAL FIBRILLARY ACIDIC PROTEIN; HUNTINGTON PROTEIN, MOUSE; INTERLEUKIN 1 RECEPTOR TYPE I; NERVE PROTEIN; NUCLEAR PROTEIN;

AMINO TERMINAL SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOACCUMULATION; CONTROLLED STUDY; CORPUS STRIATUM; CYTOTOXICITY; DISEASE SEVERITY; FEMALE; GENE MUTATION; HUNTINGTON CHOREA; KNOCKOUT MOUSE; MALE; MOUSE; NERVE DEGENERATION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; ANIMAL; BRAIN; DISEASE MODEL; GENETICS; HISTOLOGY; METABOLISM; MOUSE MUTANT; MUTATION; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; ROTAROD TEST;

MUS;

ANIMALS; BRAIN; DISEASE MODELS, ANIMAL; FEMALE; GLIAL FIBRILLARY ACIDIC PROTEIN; HUNTINGTON DISEASE; MALE; MICE; MICE, KNOCKOUT; MUTATION; NERVE TISSUE PROTEINS; NUCLEAR PROTEINS; PHENOTYPE; RECEPTORS, INTERLEUKIN-1 TYPE I; ROTAROD PERFORMANCE TEST; SIGNAL TRANSDUCTION;

EID: 77958576251     PISSN: None     EISSN: 17566606     Source Type: Journal    
DOI: 10.1186/1756-6606-3-33     Document Type: Article

References (37)

1. Molecular genetics of Huntington's disease. JF Gusella ME MacDonald CM Ambrose MP Duyao, Arch Neurol 1993 50 1157 1163 8215974
2. Huntington disease. JP Vonsattel M DiFiglia, J Neuropathol Exp Neurol 1998 57 369 384 10.1097/00005072-199805000-00001 9596408
3. HAP1 and intracellular trafficking. XJ Li SH Li, Trends Pharmacol Sci 2005 26 1 3 10.1016/j.tips.2004.11.001 15629196
4. Genetic and pharmacological inhibition of calcineurin corrects the BDNF transport defect in Huntington's disease. JR Pineda R Pardo D Zala H Yu S Humbert F Saudou, Mol Brain 2009 2 33 10.1186/1756-6606-2-33 19860865
5. Huntingtin as an essential integrator of intracellular vesicular trafficking. JP Caviston EL Holzbaur, Trends Cell Biol 2009 19 147 155 10.1016/j.tcb.2009.01.005 19269181
6. pARIS-htt: an optimised expression platform to study huntingtin reveals functional domains required for vesicular trafficking. R Pardo M Molina-Calavita G Poizat G Keryer S Humbert F Saudou, Mol Brain 2010 3 17 10.1186/1756-6606-3- 17 20515468
7. Mechanisms of disease: Histone modifications in Huntington's disease. G Sadri-Vakili JH Cha, Nat Clin Pract Neurol 2006 2 330 338 10.1038/ncpneuro0199 16932577
8. Nuclear accumulation of polyglutamine disease proteins and neuropathology. LS Havel S Li XJ Li, Mol Brain 2009 2 21 10.1186/1756-6606-2-21 19575804
9. Intranuclear inclusions and neuritic aggregates in transgenic mice expressing a mutant N-terminal fragment of huntingtin. G Schilling MW Becher AH Sharp HA Jinnah K Duan JA Kotzuk HH Slunt T Ratovitski JK Cooper NA Jenkins NG Copeland DL Price CA Ross DR Borchelt, Hum Mol Genet 1999 8 397 407 10.1093/hmg/8.3.397 9949199
10. Mouse models of Huntington's disease. LB Menalled MF Chesselet, Trends Pharmacol Sci 2002 23 32 39 10.1016/S0165-6147(00)01884-8 11804649
11. Rodent genetic models of Huntington disease. MY Heng PJ Detloff RL Albin, Neurobiol Dis 2008 32 1 9 10.1016/j.nbd.2008.06.005 18638556
12. IL-1/IL-1ra balance in the brain revisited - evidence from transgenic mouse models. S Spulber T Bartfai M Schultzberg, Brain Behav Immun 2009 23 573 579 10.1016/j.bbi.2009.02.015 19258032
13. Cytokines and acute neurodegeneration. SM Allan NJ Rothwell, Nat Rev Neurosci 2001 2 734 744 10.1038/35094583 11584311
14. Phenotypic and functional characterization of mice that lack the type I receptor for IL-1. MB Glaccum KL Stocking K Charrier JL Smith CR Willis C Maliszewski DJ Livingston JJ Peschon PJ Morrissey, J Immunol 1997 159 3364 3371 9317135
15. NF-kappaB in the survival and plasticity of neurons. MP Mattson, Neurochem Res 2005 30 883 893 10.1007/s11064-005-6961-x 16187223
16. Distinct roles of diverse nuclear factor-kappaB complexes in neuropathological mechanisms. M Pizzi P Spano, Eur J Pharmacol 2006 545 22 28 10.1016/j.ejphar.2006.06.027 16854410
17. Downregulation of NF-kappaB signaling by mutant huntingtin proteins induces oxidative stress and cell death. S Reijonen JP Kukkonen A Hyrskyluoto J Kivinen M Kairisalo N Takei D Lindholm L Korhonen, Cell Mol Life Sci 2010 67 1929 1941 10.1007/s00018-010-0305-y 20232225
18. Activation of the IkappaB kinase complex and nuclear factor-kappaB contributes to mutant huntingtin neurotoxicity. A Khoshnan J Ko EE Watkin LA Paige PH Reinhart PH Patterson, J Neurosci 2004 24 7999 8008 10.1523/JNEUROSCI.2675-04.2004 15371500
19. Interleukin-1 in the brain: mechanisms of action in acute neurodegeneration. HC Patel H Boutin SM Allan, Ann N Y Acad Sci 2003 992 39 47 10.1111/j.1749-6632.2003.tb03136.x 12794045
20. Interleukin-1 receptor antagonist. WP Arend, Adv Immunol 1993 54 167 227 8379462
21. Accumulation of N-terminal mutant huntingtin in mouse and monkey models implicated as a pathogenic mechanism in Huntington's disease. CE Wang S Tydlacka AL Orr SH Yang RK Graham MR Hayden S Li AW Chan XJ Li, Hum Mol Genet 2008 17 2738 2751 10.1093/hmg/ddn175 18558632
22. Expression of mutant huntingtin in glial cells contributes to neuronal excitotoxicity. JY Shin ZH Fang ZX Yu CE Wang SH Li XJ Li, J Cell Biol 2005 171 1001 1012 10.1083/jcb.200508072 16365166
23. Mutant huntingtin causes context-dependent neurodegeneration in mice with Huntington's disease. ZX Yu SH Li J Evans A Pillarisetti H Li XJ Li, J Neurosci 2003 23 2193 2202 12657678
24. Neurological abnormalities in a knock-in mouse model of Huntington's disease. CH Lin S Tallaksen-Greene WM Chien JA Cearley WS Jackson AB Crouse S Ren XJ Li RL Albin PJ Detloff, Hum Mol Genet 2001 10 137 144 10.1093/hmg/10.2.137 11152661
25. Huntington disease: new insights on the role of huntingtin cleavage. CL Wellington BR Leavitt MR Hayden, J Neural Transm Suppl 2000 1 17 11128600
26. beta-Secretase, APP and Abeta in Alzheimer's disease. R Vassar, Subcell Biochem 2005 38 79 103 15709474
27. Environmental neurotoxin dieldrin induces apoptosis via caspase-3-dependent proteolytic activation of protein kinase C delta (PKCdelta): Implications for neurodegeneration in Parkinson's disease. AG Kanthasamy M Kitazawa Y Yang V Anantharam A Kanthasamy, Mol Brain 2008 1 12 10.1186/1756-6606-1-12 18945348
28. Lysosomal enzyme cathepsin D protects against alpha-synuclein aggregation and toxicity. L Qiao,, et al. Mol Brain 2008 1 17 10.1186/1756-6606-1-17 19021916
29. Cathepsin D expression level affects alpha-synuclein processing, aggregation, and toxicity in vivo. V Cullen M Lindfors J Ng A Paetau E Swinton P Kolodziej H Boston P Saftig J Woulfe MB Feany L Myllykangas MG Schlossmacher J Tyynela, Mol Brain 2009 2 5 10.1186/1756-6606-2-5 19203374
30. Actions of the pro-inflammatory cytokine IL-1 beta on central synaptic transmission. JJ O'Connor AN Coogan, Exp Physiol 1999 84 601 614 10.1017/S0958067099018928 10481219
31. Cytokines and neuronal ion channels in health and disease. B Viviani F Gardoni M Marinovich, Int Rev Neurobiol 2007 82 247 263 17678965
32. Effect of cytokines on neuronal excitability. M Schafers L Sorkin, Neurosci Lett 2008 437 188 193 10.1016/j.neulet.2008.03.052 18420346
33. Blunted neurogenesis and gliosis due to transgenic overexpression of human soluble IL-1ra in the mouse. S Spulber M Oprica T Bartfai B Winblad M Schultzberg, Eur J Neurosci 2008 27 549 558 10.1111/j.1460-9568.2008.06050.x 18279308
34. Interleukin-1 mediates induction of tolerance to global ischemia in gerbil hippocampal CA1 neurons. T Ohtsuki CA Ruetzler K Tasaki JM Hallenbeck, J Cereb Blood Flow Metab 1996 16 1137 1142 10.1097/00004647-199611000-00007 8898685
35. Status epilepticus induces time-dependent neuronal and astrocytic expression of interleukin-1 receptor type I in the rat limbic system. T Ravizza A Vezzani, Neuroscience 2006 137 301 308 10.1016/j.neuroscience.2005.07.063 16289587
36. Expression of mutant huntingtin in mouse brain astrocytes causes age-dependent neurological symptoms. J Bradford JY Shin M Roberts CE Wang XJ Li S Li, Proc Natl Acad Sci USA 2009 106 22480 22485 10.1073/pnas.0911503106 20018729
37. Astrocytic expression of Parkinson's disease-related A53T alpha-synuclein causes neurodegeneration in mice. XL Gu CX Long L Sun C Xie X Lin H Cai, Mol Brain 2010 3 12 10.1186/1756-6606-3-12 20409326